pravastatin has been researched along with Hypoxia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Beck, C; Giussani, DA; Itani, N; Katzilieris-Petras, G; Niu, Y; Skeffington, KL; Smith, N | 1 |
Demachi, J; Fukumoto, Y; Ishii, N; Kagaya, Y; Karibe, A; Nakano, M; Nawata, J; Satoh, K; Shimokawa, H; Sugamura, K; Sugimura, K | 1 |
Giussani, DA; Hansell, JA; Herrera, EA; Kane, AD | 1 |
Fedak, PW; Li, RK; Li, SH; Miriuka, S; Rao, V; Verma, S; Weisel, RD | 1 |
4 other study(ies) available for pravastatin and Hypoxia
Article | Year |
---|---|
Protective effects of pravastatin on the embryonic cardiovascular system during hypoxic development.
Topics: Animals; Antioxidants; Chickens; Embryo, Nonmammalian; Female; Heart; Hypoxia; Nitric Oxide; Oxidative Stress; Pravastatin; Pregnancy; Protective Agents | 2020 |
Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1.
Topics: Actins; Animals; Bone Marrow Cells; CD18 Antigens; Cell Differentiation; Cells, Cultured; Chemokine CXCL12; Disease Models, Animal; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypoxia; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Pravastatin; Proto-Oncogene Proteins c-kit; Receptors, CXCR4; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Statin treatment depresses the fetal defence to acute hypoxia via increasing nitric oxide bioavailability.
Topics: Animals; Anticholesteremic Agents; Biological Availability; Blood Gas Analysis; Cardiovascular System; Catecholamines; Endocrine System; Female; Fetus; Hypoxia; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Pravastatin; Pregnancy; Sheep; Vasomotor System | 2012 |
Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells.
Topics: Acyl Coenzyme A; Cardiotonic Agents; Cell Survival; Cells, Cultured; Child; Endothelin-1; Heart Ventricles; Humans; Hypoxia; Myocytes, Cardiac; Nitric Oxide; Oxygen; Pravastatin; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt | 2004 |